LLY

1,006.06

+1.27%↑

JNJ

209.91

+1.6%↑

ABBV

223.8

-0.55%↓

UNH

336.55

+2.68%↑

AZN

90.26

-1.28%↓

LLY

1,006.06

+1.27%↑

JNJ

209.91

+1.6%↑

ABBV

223.8

-0.55%↓

UNH

336.55

+2.68%↑

AZN

90.26

-1.28%↓

LLY

1,006.06

+1.27%↑

JNJ

209.91

+1.6%↑

ABBV

223.8

-0.55%↓

UNH

336.55

+2.68%↑

AZN

90.26

-1.28%↓

LLY

1,006.06

+1.27%↑

JNJ

209.91

+1.6%↑

ABBV

223.8

-0.55%↓

UNH

336.55

+2.68%↑

AZN

90.26

-1.28%↓

LLY

1,006.06

+1.27%↑

JNJ

209.91

+1.6%↑

ABBV

223.8

-0.55%↓

UNH

336.55

+2.68%↑

AZN

90.26

-1.28%↓

Search

OraSure Technologies Inc

Închisă

SectorSănătate

2.57 0.78

Rezumat

Modificarea prețului

24h

Curent

Minim

2.5300000000000002

Maxim

2.64

Indicatori cheie

By Trading Economics

Venit

-30M

-14M

Vânzări

27M

27M

Marjă de profit

-50.626

Angajați

501

EBITDA

3.2M

-11M

Statistici piață

By TradingEconomics

Capitalizare de piață

-15M

180M

Deschiderea anterioară

1.79

Închiderea anterioară

2.57

Sentimentul știrilor

By Acuity

4%

96%

2 / 374 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Strong Bearish Evidence

OraSure Technologies Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

10 dec. 2025, 22:02 UTC

Câștiguri

Synopsys Sees Strong 2026 as Ansys Acquisition Boosts 4Q Revenue

10 dec. 2025, 21:46 UTC

Câștiguri

Adobe Expects Double-Digit Recurring Revenue Growth Next Year

10 dec. 2025, 23:52 UTC

Achiziții, Fuziuni, Preluări

Paramount Sends Letter to Warner Bros. Shareholders Saying Its Offer Is 'Superior' -- Barrons.com

10 dec. 2025, 23:43 UTC

Market Talk

Nikkei May Rise After Fed Rate Cut -- Market Talk

10 dec. 2025, 23:36 UTC

Market Talk

Gold Consolidates as Traders Digest FOMC Decision -- Market Talk

10 dec. 2025, 23:20 UTC

Câștiguri

Oracle Reports $16.1 Billion in Revenue, Narrowly Missing Forecasts -- 2nd Update

10 dec. 2025, 23:15 UTC

Câștiguri

Synopsys Targets Double-Digit Growth Following Ansys Acquisition -- Interview

10 dec. 2025, 22:59 UTC

Market Talk
Câștiguri
Achiziții, Fuziuni, Preluări

Adobe Expects Semrush Deal to Bring in New Users -- Market Talk

10 dec. 2025, 22:45 UTC

Market Talk

Coca-Cola's New CEO Pick Looks A Lot Like The Last One -- Market Talk

10 dec. 2025, 22:40 UTC

Câștiguri

Synopsys Stock Rises on Earnings Beat, Higher Guidance -- Barrons.com

10 dec. 2025, 22:06 UTC

Achiziții, Fuziuni, Preluări

Paramount Sends Letter to Warner Bros. Shareholders Saying Their Offer Is 'Superior' -- Barrons.com

10 dec. 2025, 22:06 UTC

Câștiguri

Oracle Reports Mixed Earnings. The Stock Is Falling. -- Barrons.com

10 dec. 2025, 22:02 UTC

Câștiguri

Synopsys Stock Rises on Earnings Beat, Higher Guidance -- Barrons.com

10 dec. 2025, 22:00 UTC

Câștiguri

Oracle Reports $16.1 Billion in Revenue, Narrowly Missing Forecasts -- Update

10 dec. 2025, 21:53 UTC

Câștiguri

Adobe Earnings Show 'Rapid Adoption' of AI Tools. The Stock Is Up. -- Barrons.com

10 dec. 2025, 21:50 UTC

Achiziții, Fuziuni, Preluări

Investors Bet That a Higher Bid for Warner Is Coming -- Update

10 dec. 2025, 21:50 UTC

Market Talk
Câștiguri
Achiziții, Fuziuni, Preluări

Financial Services Roundup: Market Talk

10 dec. 2025, 21:50 UTC

Market Talk

Health Care Roundup: Market Talk

10 dec. 2025, 21:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

10 dec. 2025, 21:45 UTC

Achiziții, Fuziuni, Preluări

Paramount Sends Letter to Warner Bros. Shareholders Saying Their Offer Is 'Superior' -- Barrons.com

10 dec. 2025, 21:33 UTC

Câștiguri

Oracle Reports $16.1 Billion in Revenue, Narrowly Missing Forecasts -- WSJ

10 dec. 2025, 21:32 UTC

Câștiguri

Oracle Reports Mixed Earnings. The Stock Is Falling. -- Barrons.com

10 dec. 2025, 21:28 UTC

Achiziții, Fuziuni, Preluări

Sverica Capital Management Announces Sale of Coastal Cloud Holdings to Tata Consultancy Services for $700M

10 dec. 2025, 21:25 UTC

Câștiguri

Adobe Earnings Show 'Rapid Adoption' of AI Tools. The Stock Is Up. -- Barrons.com

10 dec. 2025, 21:18 UTC

Achiziții, Fuziuni, Preluări

Paramount Skydance: Company Has Air Tight Financing to Deliver on Warner Bros. Offer >PSKY

10 dec. 2025, 21:16 UTC

Câștiguri

Oracle Reports Mixed Earnings. The Stock is Falling. -- Barrons.com

10 dec. 2025, 21:15 UTC

Achiziții, Fuziuni, Preluări

Paramount Skydance: Public Offer for Warner Bros. Delivers Superior Value, Faster, More Certain Path to Completion

10 dec. 2025, 21:15 UTC

Câștiguri

Oracle: 'Sold Ampere Because We No Longer Think It Is Strategic for Us to Continue Designing, Manufacturing and Using Our Own Chips in Our Cloud Datacenters' >ORCL

10 dec. 2025, 21:14 UTC

Câștiguri

Oracle 2Q Non-GAAP Operating Income Was $6.7 B >ORCL

10 dec. 2025, 21:14 UTC

Câștiguri

Oracle 2Q GAAP Operating Income Was $4.7 B >ORCL

Comparație

Modificare preț

OraSure Technologies Inc Așteptări

Consens privind evaluarea

By TipRanks

0 ratings

0

Cumpărare

0

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

N/A / 2.975Suport & Rezistență

Termen scurt

Strong Bearish Evidence

Termen mediu

Weak Bearish Evidence

Termen lung

No Evidence

Sentiment

By Acuity

2 / 374 Clasament în Sănătate

Sentimentul știrilor

Evidențe foarte puternice de creștere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Peste medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre OraSure Technologies Inc

OraSure Technologies, Inc., together with its subsidiaries, provides point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services in the United States, Europe, and internationally. The company's products include InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test, OraQuick Ebola rapid antigen test, OraSure oral fluid collection device used in conjunction with screening and confirmatory tests for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D. saliva alcohol test. It also offers genomic products under the Oragene and ORAcollect brands for collecting genetic material from human saliva; Colli-Pee collection devices for the volumetric collection of void urine samples; and microbiome laboratory testing and analytical services. In addition, the company provides microbiome products, such as OMNIgene GUT for self-collecting microbial DNA from feces or stool samples for gut microbiome profiling; OMNIgene GUT DNA and RNA collection devices; and OMNIgene GUT Dx collection device for collection of human fecal samples and the stabilization of DNA from the bacterial community. Additionally, it provides other diagnostic products, such as immunoassays and other in vitro diagnostic tests. The company markets its products to clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, commercial and industrial entities, disease risk management, diagnostics, pharmaceutical, biotech, nutrition, companion animal, and environmental markets. OraSure Technologies, Inc. was incorporated in 2000 and is based in Bethlehem, Pennsylvania.
help-icon Live chat